title: Human interferon alpha-2b: a therapeutic protein for cancer treatment.
abstract: Human interferon alpha (hIFNα) is a wide biological activity cytokine that is used in hepatitis and cancer treatments. It regulates many genes that are involved in antiviral and antiproliferative activities. This mini review focuses on human interferon alpha-2b (hIFNα-2b) as therapeutic protein for cancer treatment. The review covers hIFNα-2b molecular characteristic and its molecular mechanism by Janus activated kinase/signal transducer activation of transcription (JAK-STAT) pathway. The JAK-STAT pathway regulates not only proteins involved in inhibition of proliferation but also apoptosis. As additional discussion of clinical applications, the use of recombinant hIFNα-2b (rhIFNα-2b) as therapeutic protein in several types of cancer is also explained.
authors.affiliation: Research Center for Biotechnology, Cibinong Science Center, Jalan Raya Bogor km 46, Cibinong, Bogor, West Java 16911, Indonesia.
authors.forename: Ratih
authors.initials: R
authors.lastname: Asmana Ningrum
references.citation: Apoptosis. 2003 Jun;8(3):237-49
references.pmid: 12766484
references.citation: Trends Pharmacol Sci. 1996 Dec;17(12):450-6
references.pmid: 9014499
references.citation: Br J Cancer. 2001 May 4;84(9):1146-9
references.pmid: 11379605
references.citation: Natl Med J India. 2005 Mar-Apr;18(2):66-70
references.pmid: 15981440
references.citation: Oncologist. 2001;6(1):34-55
references.pmid: 11161227
references.citation: Cancer. 1987 Feb 1;59(3 Suppl):620-5
references.pmid: 3492260
references.citation: Protein Expr Purif. 2004 Jun;35(2):353-9
references.pmid: 15135413
references.citation: Blood. 1988 Aug;72(2):642-7
references.pmid: 3165298
references.citation: Biochem J. 2000 Oct 15;351 Pt 2:289-305
references.pmid: 11023813
references.citation: Leukemia. 2004 Feb;18(2):189-218
references.pmid: 14737178
references.citation: Eur J Biochem. 1998 Apr 15;253(2):485-93
references.pmid: 9654101
references.citation: Biochem J. 2000 Aug 1;349 Pt 3:869-76
references.pmid: 10903150
references.citation: Br J Cancer. 2000 Aug;83(4):532-8
references.pmid: 10945503
references.citation: N Engl J Med. 1997 Jul 24;337(4):223-9
references.pmid: 9227927
references.citation: Blood. 1994 May 15;83(10):2931-8
references.pmid: 8180388
references.citation: J Clin Oncol. 2005 Apr 1;23(10):2215-23
references.pmid: 15684317
references.citation: FASEB J. 2002 Oct;16(12):1680-2
references.pmid: 12206994
references.citation: Leuk Lymphoma. 1991;5(1):23-31
references.pmid: 27463206
references.citation: Cancer Immunol Immunother. 2005 Jan;54(1):1-10
references.pmid: 15693134
references.citation: Clin Microbiol Rev. 2001 Oct;14(4):778-809, table of contents
references.pmid: 11585785
references.citation: J Clin Oncol. 1996 Jan;14(1):7-17
references.pmid: 8558223
references.citation: J Intern Med. 1993 Mar;233(3):247-53
references.pmid: 8095516
references.citation: Blood. 1992 Mar 1;79(5):1111-20
references.pmid: 1371410
references.citation: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references.pmid: 21296855
references.citation: Nat Rev Drug Discov. 2008 Jan;7(1):21-39
references.pmid: 18097458
references.citation: BMJ. 1992 May 9;304(6836):1234-6
references.pmid: 1515800
references.citation: J Clin Oncol. 2002 Apr 1;20(7):1818-25
references.pmid: 11919239
references.citation: Cancer. 2002 Sep 1;95(5):1045-50
references.pmid: 12209689
references.citation: Br J Cancer. 2001 Jul 6;85(1):29-35
references.pmid: 11437398
references.citation: J Clin Oncol. 2007 May 20;25(15):1986-92
references.pmid: 17420513
references.citation: N Engl J Med. 2001 Dec 6;345(23):1655-9
references.pmid: 11759643
references.citation: Cancer Detect Prev. 1999;23(2):172-6
references.pmid: 10101599
references.citation: Pharmaceuticals (Basel). 2010 Mar 30;3(4):994-1015
references.pmid: 20664817
references.citation: Adv Drug Deliv Rev. 2002 Jun 17;54(4):547-70
references.pmid: 12052714
references.citation: N Engl J Med. 1984 Jan 5;310(1):15-8
references.pmid: 6689734
references.citation: Hepatology. 2004 Apr;39(4):880-90
references.pmid: 15057887
references.citation: J Clin Oncol. 1988 Nov;6(11):1714-21
references.pmid: 3054003
references.citation: Structure. 1996 Dec 15;4(12):1453-63
references.pmid: 8994971